Effective Inhibition of Thyroid Antigen Presentation Using Retro-Inverso Peptides in Experimental Autoimmune Thyroiditis: A Pathway Toward Immune Therapies of Thyroid Autoimmunity
Authors:
- 10 April 2023
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 33 (4) , 492-500
Abstract
Background: Autoimmune thyroid diseases (AITD) represent the most common autoimmune diseases. However, current therapies focus on relieving the symptoms instead of curing AITD, and new therapies to reverse the autoimmune attack on the thyroid are needed. HLA-DRβ1-Arg74 is the key HLA class II allele that triggers AITD by presenting pathogenic thyroglobulin (Tg) peptides that activate thyroid self-reactive T cells. We hypothesized that blocking the presentation of Tg peptides to T cells within the HLA-DRβ1-Arg74 peptide binding cleft could reverse the autoimmune response to the thyroid in AITD. Methods: The approach we used to block Tg peptide presentation within HLA-DRβ1-Arg74 is to design retro-inverso D-amino acid (RID) peptides that have high affinity to the HLA-DRβ1-Arg74 peptide binding pocket. Results: By using computational approaches and molecular dynamics simulations, we designed two RID peptides, RT-15 and VT-15, that blocked peptide binding to recombinant HLA-DRβ1-Arg74 molecule, as well as T cell activation in vitro . Furthermore, RT-15 and VT-15 blocked in vivo T cell activation by thyroglobulin in humanized NOD-DR3 mice induced with experimental autoimmune thyroiditis. Conclusions: In summary, we discovered two RID peptides that block thyroglobulin peptide binding to HLA-DRβ1-Arg74 and their presentation to T cells in AITD. These findings set the stage for a personalized medicine therapeutic approach for AITD patients who carry the DRβ1-Arg74 allele. This antigen-specific therapeutic strategy can potentially be extended to other autoimmune diseases.Keywords
This publication has 47 references indexed in Scilit:
- Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model FliesPLOS ONE, 2010
- Tg.2098 is a major human thyroglobulin T-cell epitopeJournal of Autoimmunity, 2010
- D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasmsProceedings of the National Academy of Sciences, 2010
- Employing a Recombinant HLA-DR3 Expression System to Dissect Major Histocompatibility Complex II-Thyroglobulin Peptide DynamismJournal of Biological Chemistry, 2009
- Expanding Functionality Within the Looking-Glass UniverseScience, 2009
- Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in miceProceedings of the National Academy of Sciences, 2008
- The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: Back to the futureJournal of Autoimmunity, 2007
- Arginine at position 74 of the HLA-DR β1 chain is associated with Graves' diseaseGenes & Immunity, 2004
- Structure of Antibody-Bound Peptides and Retro−Inverso Analogues. A Transferred Nuclear Overhauser Effect Spectroscopy and Molecular Dynamics Approach,Biochemistry, 2001
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945